Symbols

KPRX

Kiora Pharmaceuticals·NASDAQ

--(--)

3.31 / 10

Netural

Capital flow assessment yields 6.63/10, denoting robust fund flow characteristics. Strengths in Small trends confront pressures from overall, block, Medium, Large, and Extra-large patterns, resulting in positive liquidity outlook. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 0.00 historical weighted rating.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

100%

Buy

Hold

Sell

Strong Sell

Date2025-09-02

InstitutionHC Wainwright & Co.

Times predicted1

Historical Win Rate0.0%

What is the market sentiment for KPRX?

KPRX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.31/10 (Netural).